Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1985-10-3
|
pubmed:language |
spa
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0036-4355
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
320-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3898421-Acute Disease,
pubmed-meshheading:3898421-Humans,
pubmed-meshheading:3898421-Hypergammaglobulinemia,
pubmed-meshheading:3898421-Leukemia,
pubmed-meshheading:3898421-Leukemia, Lymphoid,
pubmed-meshheading:3898421-Lymphoma,
pubmed-meshheading:3898421-Multiple Myeloma,
pubmed-meshheading:3898421-Myeloma Proteins,
pubmed-meshheading:3898421-beta 2-Microglobulin
|
pubmed:year |
1985
|
pubmed:articleTitle |
[Serum levels of beta 2-microglobulin in malignant hemopathies].
|
pubmed:publicationType |
Journal Article,
English Abstract
|